Orally Dissolving Competition Lurks For Prevacid 24HR, Other OTC PPIs
This article was originally published in The Pink Sheet
Executive Summary
While GSK Consumer Healthcare's latest ad campaign for Prevacid 24HR features "Lurker," a fireball character who educates consumers on the risk of recurrence of heartburn, oral disintegration of an active ingredient is the latest differentiator in the OTC PPI category.
You may also be interested in...
New Parent Lonza Welcomes Capsugel's Independent Streak To Innovate
Lonza acquires Capsugel for $5.5bn cash, nearly twice as much as private equity firm KKR paid Pfizer for it, to enhance its product development and expand the market for its contract development and manufacturing services for drug and nutritional products.
User-Friendly OTC Dosage Forms Deliver Opportunity For Industry
Hermes Pharma executive Thomas Hein recommends the OTC industry consider formulating APIs in user-friendly dosage forms, rather than in traditional tablets and capsules, to provide consumers with ease-of-swallowing and additional lifestyle convenience. Charts detail consumer preferences based on recent survey.
Sanofi Adds Consumer Brands, Grows Footprint With Boehringer Ingelheim Deal
BI international brands including Mucoangin cough suppressant and Dulcolax constipation treatment and US heartburn remedy Zantac would join Sanofi's consumer portfolio including US brands Allegra Allergy antihistamines and Nasacort Allergy 24HR nasal decongestant in the firm's proposed asset swap.